Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe single biggest lever for boosting weight loss on Mounjaro is using tirzepatide as the tool it is, not the whole plan. In clinical trials, the adults who achieved the greatest results — up to around 20–21% body weight reduction — combined treatment with consistent changes to diet and activity, according to NHS guidance on tirzepatide. Mounjaro is a prescription-only medicine, meaning a GPhC-registered prescriber decides whether it is clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro reduces hunger significantly. The risk is that a sharply reduced appetite makes it easy to eat too little of the right things, rather than the right amount of better things. Protein is the priority: most clinical guidance for people on GLP-1 or dual-agonist treatment suggests keeping protein intake relatively high to protect lean muscle mass during a calorie deficit. Aim for a portion of protein-rich food at every meal (eggs, fish, chicken, legumes, dairy) even if the meal itself is small.
Fibre comes next. Slowed gastric emptying already extends fullness between meals, and fibre amplifies that effect while supporting gut health. Vegetables, oats, lentils and wholegrains are practical choices. What tends to crowd these out is not laziness but the common habit of reaching for whatever is easy when appetite is low: crackers, biscuits, highly processed convenience food. Tirzepatide reduces the drive to eat; it does not redirect that drive toward better choices automatically.
Hydration also matters more than many people expect. Nausea (one of the most commonly reported side effects, particularly around dose increases) is often worsened by mild dehydration. Consistent fluid intake across the day helps, and it supports kidney function if GI symptoms lead to reduced food and fluid intake for a few days.
Weight loss on Mounjaro can happen quickly, particularly at higher doses. Rapid loss carries a genuine metabolic risk: some of what you lose will be muscle unless you give your body a reason to hold on to it. Resistance exercise (bodyweight circuits, free weights, resistance bands) is the most effective signal. You do not need a gym membership or a structured programme. Twice a week of meaningful effort is enough to make a measurable difference to body composition.
Cardiovascular activity supports calorie balance and cardiovascular health independently. Walking is underrated here: 7,000–10,000 steps a day is a realistic target for most people and has meaningful effects on metabolic health over weeks and months. The right question is not which exercise burns the most calories on a given day, but which you will actually keep doing. For more on what realistic timelines look like, the guide to how long weight loss on Mounjaro takes sets out what the evidence suggests at each stage of treatment.
Sleep and stress are less obvious factors but genuinely relevant. Poor sleep raises ghrelin (the hunger-stimulating hormone) and cortisol, both of which can blunt the appetite-reducing effect of tirzepatide. If you are sleeping badly or under sustained stress, it is worth flagging with your prescriber or GP, not just pushing through.
Tirzepatide begins at 2.5mg. That first pen's job is to let your system adjust, not to produce dramatic results; many people notice only modest changes in the first four weeks. The dose is then typically increased by your prescriber in four-week steps, based on tolerability and response. Attempting to accelerate that schedule, skip doses or restart without clinical input can undermine progress and increases side-effect risk.
Consistency with your injection day makes a practical difference. Keeping the pen in the fridge door alongside items you open every morning creates a reliable visual cue. If you are not seeing the progress you expected despite being on a therapeutic dose for several months, the reasons why weight loss stalls on Mounjaro are worth reviewing, a plateau after initial progress is different from no response at all, and the appropriate response differs too.
It is also worth understanding what to expect early on. The picture in week one looks quite different from weeks eight through twelve; comparing yourself to someone at a different stage or dose is rarely useful. SURMOUNT-1 (a 72-week trial of 2,539 adults, with results published in the New England Journal of Medicine) showed average weight reductions of around 20–21% at the 15mg dose. Those are averages across a large population, not a promise about your own trajectory; individual responses vary and are shaped by the factors covered above.
Some questions around boosting results (changing meal timing, adjusting activity, managing nausea) can be worked through with guidance from your prescriber or a registered dietitian. Others require clinical input directly. Dose changes, concerns about how the medicine is affecting you, and any symptoms that worry you are clinical matters. Severe or persistent stomach pain that radiates to the back should be treated as urgent; the MHRA's Yellow Card service also accepts reports of suspected side effects from patients directly.
For people who are thinking about treatment and want to understand what is involved before committing to anything, the overview of how long Mounjaro is used for weight management explains the longer picture, including what happens when treatment ends. Private treatment costs are a reasonable question too; the Mounjaro cost page covers what affects pricing and what any legitimate price should include.
If you have recently had a baby and are wondering whether you can start treatment yet, our page on how long after giving birth you can take Mounjaro covers the clinical guidance on timing. If you are ready to find out whether tirzepatide is clinically suitable for you, check your eligibility with our prescribers, every consultation is reviewed the same day by a GPhC-registered Independent Prescriber, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.